Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allos Therapeutics: Prospects for FDA Approval of Folotyn Are Healthy
Seeking Alpha
Friday, September 4, 2009 - 7:11am
tags:
Allos, Folotyn, FDA
Bayer's Bold New Bet Fails to Rain on Spectrum Pharma
Seeking Alpha
Friday, September 4, 2009 - 6:21am
tags:
Bayer, Spectrum Pharmaceuticals
Abbott: Now That's How to Grow a Company!
Motley Fool
Friday, September 4, 2009 - 6:19am
tags:
Abbott Laboratories, Merck, Schering Plough, Visiogen, M&A
Elan dealt a blow with Biogen ruling
FT.com
Thursday, September 3, 2009 - 10:00pm
tags:
Elan, Biogen Idec, JNJ
Merck: 3 Schering-Plough directors to join board
Yahoo/AP
Thursday, September 3, 2009 - 9:59pm
tags:
Merck, buyouts, reorganization, Schering Plough
Shire wins U.S. approval for Intuniv drug
Reuters
Thursday, September 3, 2009 - 5:23pm
tags:
Shire, Intuniv, FDA, ADHD
Pfizer whistleblower's ordeal reaps big rewards
Yahoo/Reuters
Thursday, September 3, 2009 - 5:21pm
tags:
Pfizer, whistleblowers, Bextra
Analyst says Savient Pharma could be bought out after meeting with FDA over gout drug
Yahoo/AP
Thursday, September 3, 2009 - 2:04pm
tags:
Savient, FDA, gout, M&A, Krystexxa
Panel Backing for Allos' Drug
Yahoo/Zacks.com
Thursday, September 3, 2009 - 2:03pm
tags:
Allos, FDA, Folotyn
Congress considering plan to allow 'biosimilars' to come to market
Marketwatch
Thursday, September 3, 2009 - 2:00pm
tags:
biogenerics, generics
Is Sepracor the Right Prescription for Dainippon Sumitomo?
WSJ Online
Thursday, September 3, 2009 - 10:53am
tags:
Sepracor, buyouts, Dainippon Sumitomo
Order In The Court! New Date for Biogen/Elan Hearing
InVivo
Thursday, September 3, 2009 - 10:50am
tags:
Biogen Idec, Elan
Merck launches eye pressure drug Saflutan in UK and Spain after regulatory approval
Yahoo/AP
Thursday, September 3, 2009 - 10:39am
tags:
Merck, UK, Spain, Saflutan
Valeant's Six New Value Aligned Pay Practices
Seeking Alpha
Thursday, September 3, 2009 - 10:37am
tags:
Valeant Pharmaceuticals
[video] Bio-Tech High Times
TheStreet.com
Thursday, September 3, 2009 - 10:36am
tags:
biotech, Spectrum Pharmaceuticals, Novavax, Biocryst
FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines
Pharmaceutical Processing
Thursday, September 3, 2009 - 10:35am
tags:
FDA, postmarketing studies
Merck’s Latest Headache: First Fosamax Case Goes to Trial
WSJ Online
Thursday, September 3, 2009 - 10:32am
tags:
Merck, lawsuits, Fosamax, osteoporosis
Cancer drugs rising to top of sales pyramid
Fierce Pharma
Thursday, September 3, 2009 - 8:47am
tags:
cancer, drug sales
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Bloomberg
Thursday, September 3, 2009 - 8:45am
tags:
Bayer, Algeta, Alpharadin, prostate cancer
Novartis Swine Flu Vaccine Shows Early Promise
Smart Money
Thursday, September 3, 2009 - 8:44am
tags:
Novartis, swine flu, vaccines, H1N1

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.